Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001252 · ClinicalTrials.gov registry record
Human Movement Database
A clinical trial of Movement Disorder, sponsored by National Institutes of Health Clinical Center (CC).
- Recruiting
- Registry status
- 7,500
- Enrollment target
- 1
- Study location
NCT00001252: Recruiting study of Movement Disorder, sponsored by National Institutes of Health Clinical Center (CC).
NCT00001252 is a study of Movement Disorder that is actively recruiting participants, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 7,500 participants, above the 3,290-participant average among 6 other Movement Disorder trials with a reported enrollment target (128% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001252, a study of Movement Disorder, is actively recruiting participants, sponsored by National Institutes of Health Clinical Center (CC).
- RECRUITING
- Registry status
- 7,500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will collect information on the different ways people control limb and body movements. This information will be used to develop a database on normal movements and adaptive movements of people who have diseases that affect the way they move. The database will serve as a tool to improve diagnosis and treatment of patients with movement-related problems. Volunteers from one month old to old age who have normal movement patterns or who have developed different ways to perform movement tasks may be eligible for this study. A physician or physical therapist will screen candidates to determine their strength, flexibility and range of motion of joints. Participants will be asked to perform movements such as walking, walking up or down stairs, standing quietly or reaching for an object or using treadmill. For the test, the arms and legs are wrapped with a soft, rubber-like material to which small plastic reflective balls are attached. A piece of firm material called a shell may be attached to the rubber sleeves or other areas of the body. Then the volunteer performs the specified task several times while special cameras record the movement. These cameras will record the positions of the reflective balls during movement and may show the person s face or body. Electrical activity in the muscles also may be measured, using small metal electrodes attached to the surface of the skin with an adhesive bandage.
Primary Outcome
Strength and spasticity testing both include torque or force measurements as the primary outcomes. Balance testing typically yields the amount, velocity and direction of sway in response to different conditions or perturbations.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,500 participants |
| Start Date | 1995-03-13 |
What NCT00001252 shows while recruiting
NCT00001252 is an observational study that tracks outcomes without assigning an intervention. Its 7,500 participants enrollment target places it among the larger protocols in the corpus, above the 3,290-participant average among 6 other Movement Disorder trials with a reported enrollment target (128% higher).
The record links to 1 condition, with Movement Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT00001252 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001252 about?
NCT00001252 is a clinical study titled "Human Movement Database". This study will collect information on the different ways people control limb and body movements. This information will be used to develop a database on normal movements and adaptive movements of people who have diseases that affect the way they move. The database will serve as a tool to improve dia...
What is the current status of trial NCT00001252?
This trial is currently recruiting. The enrollment target is 7,500 participants. The study started on 1995-03-13.
What conditions does trial NCT00001252 study?
This clinical trial studies the following conditions: Movement Disorder.
Who is sponsoring clinical trial NCT00001252?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001252 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Movement Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Genetic Characterization of Movement Disorders and Dementias
RECRUITING
-
Natural History Protocol for Movement Disorders
RECRUITING
-
Phenotype/Genotype Correlations in Movement Disorders
RECRUITING
-
Cholinergic Receptor Imaging in Dystonia
COMPLETED
-
Diagnosis and Natural History Study of Patients With Neurological Conditions
COMPLETED
-
Magnetic Resonance Imaging Studies of Motor and Thought Processes
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
- NCT05199701 · 7,500 participants · NA
Prospective Case Collection Study for New Mammography Technologies
- NCT06112418 · 7,500 participants · NA
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI